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ABSTRACT  
Objective: The purpose of the work was the assessment of the GalenIQ 720 flowability as a functionality parameter of the excipient, comparing two 
different methods.  
Methods: The evaluated parameters were the powder flow through different size orifices and the compressibility index, as absolute values and as 
values relative to Helmcel 200. The parameters determined with pure excipients and in mixtures with a model drug, metronidazole.  
Results: The compressibility index is a specific measurement for each powders blend that allows the assessment of its overall flow properties. 
Flowability, expressed as the flow rate, shows so many different results as orifices are being tested. Both methods exhibit comparable results only 
by wide orifice sizes where the interaction with de orifice walls is minimized. The flow rate increases progressively, mostly in a potential 
relationship, with an increasing orifice diameter. The flow rate of GalenIQ 720 attains a maximum with 0.4-0.8% magnesium stearate.  
Formulations containing GalenIQ 720 show about 2.8 times greater flowability than those containing Helmcel 200 while the flowability of GalenIQ 
720 is about 8.7 times greater than that of Helmcel. The presence of metronidazole attenuates the differences observed by the flowability of pure 
excipients and its spread.  
Conclusion: Both methods consistently show a comparable improvement of metronidazole flowability with GalenIQ 720 and a deterioration of the 
same with Helmcel 200. The knowledge of the individual materials flowability allows the inference of their effect on the flowability of their mixtures 
but not the magnitude of this effect. 
Keywords: Powder flow, Compressibility index, Surrogate functionality, Explicit functionality, Relative functionality, Metronidazole, Lubricants.  
 
INTRODUCTION 
Solid dosage forms are heterogeneous systems composed of 
particles with different physical and chemical properties. The 
performance of such systems by blending, powder flow and 
compaction is critical for manufacturing, transport and scaling-up of 
the products. Powders are the most used materials in the 
pharmaceutical industry and are difficult to be characterized. This is 
attributed to their own heterogeneity and tendency to segregate in 
the course of their processing and transport. This makes difficult the 
prediction of their functionality [1]. 
Pharmaceutical products have very strict requirements in terms of 
content uniformity, consistency, stability during storage, transport 
and shelf life, which requires an exceptional degree of control in the 
manufacturing process [2]. 
During manufacture active ingredients and excipients are subjected 
to mechanical tensions, for example during charging and 
discharging, grinding, mixing, extrusion, fluidizing, dispensing, 
compression and coating. Therefore, a concern during the 
formulation is the understanding of the potential response of the 
solids to mechanical stresses throughout the development of a 
product and in the production line. Understanding, 
characterizing and predicting the properties of the powders are 
important aspects in the pharmaceutical industry in the 
development and manufacture [3].  
The manufacture of pharmaceutical solid dosage forms involves 
several processes. These processes are very sensitive to powder 
characteristics such as flowability and apparent density, parameters 
being to a certain extent interrelated and which affect the quality of 
the final product [4].  
The powder flow is a key factor in the series of processes involved in 
the manufacture of pharmaceuticals such as direct compression 
tablets and hard gelatin capsules. These products must achieve an 
optimal powder flow in order to obtain end products with an 
acceptable content uniformity, weight variation and physical 
consistency. Knowledge and subsequent control of the 
characteristics of the powders is very important in the development 
and processing of solid dosage forms [5]. 
The active ingredients are a major constraint in the formulation. 
Excipients and the manufacturing process are selected to address 
the deficiencies that may present the drug. This emphasizes the 
functionality of each excipient and the benefits obtained from each 
unit operation during manufacture [6]. 
Excipients are a very diverse group of materials with a wide range in 
their properties. They are used in many different products to 
provide different functionalities, depending on particular 
applications. The functionality has been defined as a desirable 
property of a material that helps in manufacturing, facilitating it and 
improving the quality or performance of pharmaceutical products. 
In the context of the formulations and pharmaceutical products, 
each formulation has its particular functionality requirements. 
One way to verify the functionality of an excipient is the 
identification of surrogate tests that have some relation to the 
required functionality. Such tests have been defined as 
characteristics related to functionality or performance tests [7]. 
In general, the utility of testing functionality includes: a) 
determining the properties of materials, for purposes of quality 
control, b) predicting the performance of materials in a formulation 
using surrogate functionality and c) comparing the functionality of 
excipients of different origin and different physical or chemical 
characteristics [8]. 
The selection of properties that define the functionality of the 
excipients is considered a critical activity. In the development of a 
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dosage form this selection is used to delimitate the design space. The 
design space is defined as the combination and interaction of the 
multidimensional input variables, in example, the attributes of the 
materials and process parameters that have been shown to 
contribute to the quality assurance [9]. 
The availability of many test methods indicates the difficulties in 
defining the properties of the powders. Unfortunately, many 
methods have limited value, particularly in the development of the 
process because:  
• They show only one aspect of the behavior of the excipients. 
• They do not simulate the conditions occurring in the process. 
• Generate data that does not directly correlate with performance in 
the process. 
• They are not well defined and therefore the results are not repeatable 
or reproducible between one company and another, between one place 
and another and even between an operator and other [9]. 
Various methods are available for determining the flow properties of 
powders. The methods include measuring the angle of repose, the 
bulk density of poured powder, the tapped bulk density of the 
powder, the Carr's compressibility index and the Hausner ratio. 
These methods are recommended by the pharmacopeia for 
evaluating flowability of powders and are widely used in industrial 
applications [10-12].  
Compressibility is the property that reflects the ability of the powder 
to reduce its volume when subjected to normal stress. The 
compressibility is defined as the change of volume of the powder 
under a normal pressure and is an indicator of flowability. It is often 
expressed using the Hausner ratio or the Carr index [13-15].  
Hausner ratio or Hausner index (HI) is the ratio of the density of the 
tapped powder (Dtp) divided by the bulk density of the poured powder 
(Dpp) [4, 10]. This index is calculated according to the equation:  
                                      HI = Dtp/Dpp                    ……… Eq.1 
The higher the Hausner ratio value (HI), the lower the flowability of 
the powder. If the HI of a powder is greater than 1.4 the powder is 
considered cohesive and therefore has problems in flowing; a HI 
lower than 1.25 characterizes a free flowing powder [2, 5, 16]. 
Another parameter used to evaluate the flowability of the powders is 
the compressibility index or Carr index (CI), and is again a function 
of the bulk density of the poured powder and the density of the 
settled or tapped powder. The compressibility is a proposed test by 
Carr for assessing powder properties, the compressibility index 
measures the tendency of a powder to consolidate (volume change) 
[5, 14-15].  
This compressibility index is calculated according to the equation:  
                                  …………. Eq. 2 
The compressibility index is inversely related to flowability. The 
greater the compressibility of a particulate solid, the lower its ability 
to flow. A powder having a compressibility index lesser than 20% is 
considered to have good flowability [5, 17]. 
Another indicator of the flow properties of powders commonly used 
is the flow rate and is defined as the time it takes to move a certain 
amount of powder through a funnel having a well-defined opening. 
Such measurements have demonstrated the dependence of the 
powder flow of the powder particle size, particle surface area, shape, 
and porosity, the air permeability through the powder bed, the 
electrostatic charge and the moisture [14]. 
With the aim of facilitate the powder flow, there are some methods 
that include an element that facilitates or promotes the flow of the 
powders as the use of vibration or a spatula. 
Unlike compressibility indexes, there is no scale of the goodness of 
the flow rate, because the rate is dependent, critically, upon the 
method used. Furthermore, although flow tests give information 
about what is the flow rate, you cannot know to what can be 
ascribed this rate. 
Although it can be thought that methods such compressibility 
indexes and the flow through an orifice are "primitive" exists in 
literature sufficient information indicating that these methods can 
be correlated with manufacturing experience and are therefore of 
importance [18].  
The complexity and challenge of measuring an abstract characteristic 
as the powder flowability open space to consider to where science and 
industry is guided. Probably to something more practical, that is, to 
know what the problem is and how we can solve it [18].  
The purpose of measuring the flowability of powders as a 
functionality parameter is based on concepts related to a better 
formulation, to reduce the cost of process development, to improve 
the quality and consistency of products and to save storage costs 
when optimizing, packaging, handling and transport. This parameter 
would help to evaluate a possible replacement of materials, the 
development of a formulation, the process development, improve 
the quality and management of products and fulfill the regulations of 
the health authorities 
MATERIALS AND METHODS 
[19]. 
GalenIQ 720 is a form of spherical agglomerated isomalt used for 
direct tableting and for filling capsules. Chemically it is disaccharide 
alcohol in a 1:1 ratio of 6-O - D-glucopyranosyl-D-sorbitol and 1-O - 
D-glucopyranosyl-D-mannitol dihydrate. It is found in 
pharmacopoeias as isomalt. Due to its properties as its taste and low 
calorie content, which makes it suitable for diabetics, as well as its 
low hygroscopicity offers advantages over other polyols when 
formulated into pharmaceutical products. Particularly, it is used as 
an excipient in tablets [20-21].  
The purpose of this study is to evaluate the functionality of GalenIQ 
720 as an excipient for direct compression, using the powder flow 
through funnels with different size openings as a functionality 
parameter and comparing it again the Carr’s compressibility index 
and the Hausner ratio. The measurements are absolute and relative 
to the functionality of a widely used excipient such as 
microcrystalline cellulose type 102. Functionality tests are surrogate 
using pure excipients and explicit using mixtures with other 
excipients and the drug metronidazole. 
Material  
The materials used in this study were: microcrystalline cellulose 
type 102, Helmcel 200, obtained from Helm Mexico, batch numbers 
50463 and 17649; agglomerated isomalt (Ph Eur, BP, USP-NF), 
GalenIQ 720, BENEO-Palatinit GmbH, batch number L906; 
magnesium stearate, lot A47043 from Helm Mexico and 
metronidazole from Química Alkano SA de CV, batch number 
03121402, with a purity of 99.31%. The drug and excipients were 
used as received. 
Methods 
Preparation of mixtures 
Corresponding amounts of the materials were weighed to obtain 30g 
of metronidazole mixtures with different proportions of each 
excipient: 50%, 75%, 62.5%, 25%, 37%, 85% and 95%. The powders 
were transferred to a V blender adapted to a variable speed motor, 
Roto-Torque Cole-Parmer, model 7637, for carrying out the mixture 
at 33 rpm for 20 minutes. Mixtures of metronidazole with GalenIQ 
720 were further added of 1% of magnesium stearate, to decrease 
their adhesion to compression tools. Mixtures of GalenIQ 720 with 
magnesium stearate were made with lubricant proportions of 0.4, 
0.8, 1.0, 1.2, 1.6 and 2.0%, mixing for 20 minutes. 
Bulk density and tapped density of powders  
To determine the bulk density of a poured powder it is weighed 
approximately 30 g of the corresponding material. The powder is 
gently poured through a funnel of known diameter to a graduated 
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cylinder of 100 ml which is mounted on a tapper, in a vertical 
position; registering the volume occupied by the powder (volume of 
the poured powder). If the powder level is not uniform, the marks of 
the minimum and the maximum of the volume are taken to calculate 
the average and with this the volume. The resulting volume is 
recorded. The bulk density of the poured powder is calculated by 
dividing the mass of the sample by its bulk volume. 
Once the bulk volume of the powder is recorded, the powder in the 
graduated cylinder is tapped from a height of 1.5 cm, by the tapper. 
The tapper is set at a constant speed of 50 taps per minute. The 
tapping of the sample is carried out in cycles of 10 taps. The volume 
occupied by the powder is recorded, repeating the operation as 
often as necessary, until obtaining 3 equal consecutive 
measurements. This is the volume of the tapped powder. The bulk 
density of the tapped powder is calculated by dividing the mass of 
the sample by the volume occupied by the tapped powder. 
These measurements are repeated five times with each one of the 
different funnels being studied (opening diameters of 3, 6, 8, 10 and 
14 mm). The powders are sieved through a mesh number 20 after 
each evaluation. The average of 5 measurements is taken as the bulk 
density of the poured or tapped powder as applicable.  
With these measurements the Hausner Ratio and the 
Compressibility Index are calculated, to judge the rheological 
properties, according to Equations 1 and 2. 
Assessment of the flow rate of the powders  
In a balance the material is weighed (approximately 30 g) and its 
flow rate assessed using a glass funnel with an opening of known 
diameter. This funnel is placed on a 100 ml graduated cylinder 
mounted on a tapper. The sample is gently poured into the funnel 
whose bottom opening was blocked. While unlocked, the tapper 
starts the movement. The powder flows through the orifice of the 
funnel, falling to the bottom of the cylinder. The time it takes to 
move the total powder poured through the funnel is registered. The 
flow rate is calculated by dividing the sample mass by the time.  
The assay is repeated 5 times for each one of the selected funnels 
(opening diameters of 3, 6, 8, 10 and 14 mm), sieving the powder 
through a mesh number 20 after each measurement. The average of 
the 5 repetitions is taken as the flow rate. 
RESULTS AND DISCUSSION 
Assessment of flowability of individual materials  
The compressibility index was assessed by allowing fall the powder 
through funnels with orifices of different size. The values obtained 
for the compressibility indexes are depicted in Figure 1. It is 
observed a slight tendency of these values to increase with 
increasing orifice diameters, although this tendency is small.  
 
 
Fig. 1: Compressibility indexes (%) obtained for GalenIQ 720, 
Helmcel 200 and Metronidazole, using funnels with different 
opening sizes. 
According to compressibility indexes the flowability of Helmcel 200 
is the worst, showing an average compressibility index of 21.7%, 
which means that its flow properties are acceptable. Avicel 102, 
Helmcel 200 innovator, has shown compressibility indexes of 16-
16.3, qualifying as a material with relatively good or intermediate 
flow properties. While the classification for Helmcel 200 is similar, 
the current compressibility index is clearly higher. This is 
attributable to different conditions of the measurement process. 
A better flow is observed with GalenIQ 720, with an average 
compressibility index of 13.8%. This means a rating of good flow 
properties. This value is similar to that published by the provider 
[23], 10%, even if the current value is also somewhat higher. In the 
same classification is found metronidazole, although this material 
flows better with an average compressibility index of 12.1%. 
The flowability of GalenIQ 720 and metronidazole would be 
considered sufficient to process direct compression tablets. For 
example, it was observed that Tramadol. HCl tablets containing 66% 
of GalenIQ 720 and showing a Compressibility Index of 14.6% allow 
a tablet weight uniformity of 246 mg ± 12, when compressed in a 
rotary tablet press Rimek Minipress [24]. 
The flowability of powders is intuitively defined as the ease of flow 
and is related to the change in position of the particles with respect 
to each other within the assembly forming a powder. The dynamic 
behavior of the powder appears to be mainly determined by 
interparticle forces and the packing structure [25].  
Interparticle forces and particle-packing would be displayed in the 
compressibility index. Higher compressibility index values 
corresponding with higher interparticle forces and/or denser 
packings. The compressibility index is inversely proportional to the 
flowability of powder, so that the inverse of this ratio may be 
considered as indicative of powders flowability. Thus, the flowability 
of GalenIQ 720 corresponds to 1/13.78 = 0.0726, Helmcel 200 with a 
value of 1/21.73 = 0.0460 while metronidazole exhibits a value of 
1/12.09 = 0.0827. 
The above mentioned values are indicative of the absolute 
flowability. However, the powder flow can also be calculated as a 
relative value, for example, relative to Helmcel 200 (microcrystalline 
cellulose type 102). In this sense, GalenIQ 720 has a relative flowability 
of 1.58 times that of Helmcel 200 while metronidazole has a 
comparable relative flowability of 1.80 times that of Helmcel 200.  
Microcrystalline cellulose type 102 (Avicel PH102) has been 
considered at the boundary between an acceptable and a poor 
flowing excipient for tableting in high-speed machines. For this 
reason, it has been used as a reference material for judging the goodness 
of the flow properties of formulations. Powders showing flow properties 
lower than microcrystalline cellulose type 102 have been found to have 
problems of flowability that must be corrected [26]. 
In the same way and using the same experimental data as before the 
Hausner ratio was assessed. The obtained values are depicted in 
Figure 2. It is noted an increase of the Hausner ratio with an 
increasing orifice diameter of the funnels through which the powder 
was flowing. Even if this increase is limited, it is similar to that 
observed using the Compressibility Index. 
It is observed that Helmcel 200 shows an average Hausner Ratio of 
1.28. This value means that the flowability of the powder can be 
considered as acceptable. Currently, Helmcel 200 is the worst 
flowing material. A better flow is displayed by GalenIQ 720, with an 
average of 1.16, which indicates that it possesses good flow 
properties. The best flowing material is metronidazole, even if it 
displays a Hausner ratio similar to that of GalenIQ 720, 1.14. Both 
materials are considered to have good flow properties. As can be 
seen, these results lead to similar conclusions as those of 
compressibility indexes and will not be displayed anymore in this 
discussion of results. 
The materials under study were examined in their flow rate, taking 
the time that a certain amount of mass of the powder requires to 
pass through a funnel with an orifice of a well-defined size. The flow 
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rate was determined using funnels with orifices of different size, 3, 6, 
8, 10 and 14 mm. 
 
 
Fig. 2: Hausner ratio values obtained for GalenIQ 720, Helmcel 
200 and Metronidazole, using funnels with orifices of different 
size. 
 
Measuring the flow rate may alter its repeatability because the air in 
the powders can be removed and the powders can form agglomerates 
[27]. This source of variation in the assessment of the flow rate was 
avoided by aerating the powder, sieving after each test. 
Unlike the above determinations of compressibility index, in case of 
the flow rate and as observed in Figure 3, there is not a single value 
indicative of the flowability but a number of them. The flowability of 
the powders, expressed as the flow rate, increases with an 
increasing diameter of the orifice though which the powders flow. 
The flow rate has been observed to be proportional to a power of the 
orifice diameter [28]. Currently, metronidazole increases its flow 
rate in a potential relationship, as the orifice diameter through 
which the powder flows is increased. Similarly, there is also a 
potential relationship of an increasing flow rate as the orifice 
diameter increases for Helmcel 200. Further, GalenIQ 720 displays a 




Fig. 3: Flow rate of powders of GalenIQ 720, Helmcel 200 and 
Metronidazole, when flowing through glass funnels with 
different size openings. 
Helmcel 200 consistently displayed again the worse flowability. This 
flowability was calculated for an orifice of 6 mm as 257 mg/s, while 
GalenIQ 720 shows a powder flow rate, calculated for the same 
orifice size, of 3381 mg/s. The best flowing material was 
metronidazole with a calculated powder flow rate of 4275 mg/s. The 
flow rate results show a comparatively similar flowability of the 
different materials as that seen before by the results of 
Compressibility Indexes. 
The flow rate of GalenIQ 720, related to the flow rate of Helmcel 200 
is 13.1 times greater, while the flow rate of metronidazole is 16.6 
times higher. Although these relative flowabilities are almost 10 
times higher than those calculated with the compressibility indexes, 
the comparative flowability among the different materials is 
preserved. It means that metronidazole flows only slightly better 
than GalenIQ 720 and both flow much better than Helmcel 200. The 
flowability of Helmcel 200 is much lower than that of metronidazole 
and GalenIQ 720.  
Furthermore, the values of the relative flow rate decrease 
logarithmically with an increasing orifice diameter. For a 14 mm 
orifice the flow rate of GalenIQ 720 is 4.6 times greater than that of 
Helmcel 200, much lesser than that calculated for an orifice of 6 mm 
– 13.1. In the same manner, metronidazole shows a relative flow rate 
5.8 times greater than that of Helmcel 200, compared to a value of 
16.6 observed before. These values are about 3 times higher than 
those determined with the compressibility index. When the flow rate 
is extrapolated to an opening of 43 mm the relative flowability of 
metronidazole and GalenIQ 720 are similar to those calculated with 
the compressibility index. The relative flowability of the powders 
assessed with the flow rate and Compressibility Indexes are 
comparable only when the powders flow freely, freely enough to 
overcome the restriction created by the walls of the funnel orifice. 
Figure 4 depicts the relationship between the compressibility index 
and the flow rate calculated by regression (Fig. 3) for the studied 
materials. As can be seen, the same relationship holds for all 
different orifice sizes that were tested.  
 
 
Fig. 4: Logarithmic relationship of compressibility indexes of 
GalenIQ 720, Helmcel 200 and metronidazole, against their flow 
rate, calculated by regression for orifices of different size. 
 
The powders flow rate is linked to an opening size and not only to 
the properties of the flowing material while the compressibility 
index and the Hausner ratio are more linked to powder properties. 
In general, the compressibility index and Hausner ratio are related 
to powders properties and tell us if the flow properties of powders 
are better or worse. On the other hand, the flow rate gives results 
depending not only on the materials properties but depending also 
on the interaction of the powder with the orifice. The flow rate is 
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more useful to predict the performance of materials using 
processing equipment with orifices or means of access that restrict 
the powders flow. 
Effect of magnesium stearate on the flowability of GalenIQ 720 
The excipient GalenIQ 720 is commonly used to formulate direct 
compression tablets concurrently with a lubricant, because it sticks 
or adheres to compression tools. However, the functionality of the 
carrier to improve flowability of the formulations may be affected by 
the lubricant. Therefore, the flowability of the excipient and their 
mixtures with magnesium stearate was assessed using the 
compressibility index, adding the powder through funnels with 
different orifice sizes. 
Figure 5 depicts the Compressibility Index for GalenIQ 720 and the 
average obtained for mixtures with varying concentrations of 
magnesium stearate up to 2%. As in previous cases, it is observed 
that there is a minor increase in the compressibility index as the 
diameter of the orifice through which the powder is added increases. 
The addition of magnesium stearate lessen in an important manner 
the compressibility index, this meaning an increase in the flow rate 
of the excipient.  
 
 
Fig. 5: Effect of the orifice diameter and the addition of 
magnesium stearate on the compressibility index of GalenIQ 
720. 
 
Among the possible effects of a lubricant such as magnesium 
stearate on the flowability of powders is an increased flowability. 
This is attributed to formation of a lubricant layer on the particles. 
This layer may fill in the surface roughness of the particles. This has 
been suggested for the case of Avicel PH-101 and PH-102 [22].  
Pharmaceutical powders are composed of various particle sizes. In a 
mixture of these particles, the fine tend to occupy the empty spaces 
left by the large ones, increasing their packing and obstructing their 
flowability. In spite of this, when the amount of these fine particles is 
small, they might function as rolling bearings for the large particles, 
facilitating its slipping and flowability [28]. This factor would also 
contribute to the mechanism of action of magnesium stearate, to 
increase the flowability of powders. 
The above mentioned effects of magnesium stearate has been 
observed before with materials such as lactose and spray dried 
granules, Di-Pac, Lactose-316 Fast Flo and binary mixtures of Avicel 
PH102 and lactose 316 (1:1). The addition of 1% magnesium 
stearate improved the flow properties of these materials. However, 
larger amounts of lubricant do not always increase the improvement 
of flowability of powders. Lubricant proportions between 2 and 5% 
may decrease the powders flowability. There appears to be an 
optimum of the lubricant proportion to improve the flowability of 
each powder. The addition of higher amounts of lubricant may 
produce no further effect or deteriorate the optimal flow properties 
of powders [29-30]. 
Figure 6 depicts the results obtained for the flow rate of GalenIQ 720 
and its mixtures with magnesium stearate in different proportions. It 
is observed that additions of magnesium stearate of 0.4-0.8% 
increases the flow rate of GalenIQ 720. Higher proportions of the 
lubricant no longer increase the powder flow rate but lessen it or keep 
it in a given magnitude. The current flow rate results are in agreement 
with the above mentioned data found in literature [29-30]. 
 
 
Fig. 6: Effect magnesium stearate on the flow rate of GalenIQ 
720, assessed with glass funnels with openings of different size 
(mm). 
 
In order to better contrasting the overall effect of magnesium 
stearate, it was used the average of results obtained with mixtures of 
GalenIQ 720 containing different proportions of the lubricant. Figure 
7 shows an improvement in the flow rate of GalenIQ 720 in its 
mixtures with magnesium stearate when the powders flow through 
different size orifices. The flow rate of mixtures with the lubricant is 
in all cases greater than that observed for pure GalenIQ 720.  
The improvement in flowability of GalenIQ 720 obtained with the 
lubricant is about the double (122%) when determined with the 
compressibility index while it ranges from 41% for an orifice size of 
6 mm to 44% for an orifice of 14 mm, when determined with the 
flow rate (data calculated by regression, Fig. 7). It is clear the 
improvement of flowability of GalenIQ 720 after addition of the 
lubricant but its magnitude is quite different depending on the 
method used to assess it.  
 
 
Fig. 7: Powder flow rate of pure GalenIQ 720 compared to the 
average of the flow rate of its mixtures containing up to 2% 
magnesium stearate when flowing through different size 
orifices. 
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GalenIQ 720 explicit functionality in a formulation of 
metronidazole 
While the flowability of the individual powders has been described 
with several parameters, these parameters are not able without 
difficulty to predict the flowability of mixtures thereof. In a study on 
the properties of mixtures of powders of chloroquine phosphate and 
calcium phosphate, it was found that when the powders are mixed in 
different proportions the properties of the mixtures could not be in-
between of those of the constituent powders. This behavior is called 
anomalous and referred to the changes that occur in the packing 
arrangement of the particles of the powders [31]. 
Figure 8 depicts the changes in the compressibility index of 
metronidazole when the ratio of GalenIQ 720 in its mixtures is 
modified. The compressibility index decreases as the ratio of 
GalenIQ 720 increases. This is equivalent to an increase of the 
powder flow rate.  
Even if both materials have good and similar flow properties the 
observed effect seems to be due to a lesser adhesion between 
different particles compared to the cohesiveness between particles 
of the same kind. This circumstance allows a greater flow by the 
simple fact of mixing. Therefore, one could say that GalenIQ 720 is a 
pharmaceutical excipient which betters the flow properties even of 
the good flowing metronidazole. According to compressibility 
indexes, GalenIQ betters the flowability of metronidazole decreasing 
by a factor of about 0.057% its calculated compressibility index by 
every unit percentage of the added excipient. This is equivalent to 
about 0.5% of its original value. 
 
 
Fig. 8: Effect of different proportions of GalenIQ on the 
compressibility index (%) of metronidazole. 
 
 
Fig. 9: Effect of GalenIQ 720 on the flow rate of its mixtures with 
metronidazole, assessed with funnels with different size 
openings (mm). 
Figure 9 shows the flow rate of metronidazole containing different 
proportions of GalenIQ 720, when measured in funnels with 
different size orifices. After addition of increasing proportions of 
GalenIQ 720 there is first an increase and then a decrease in the flow 
rate. A further increase in the proportion of GalenIQ 720 displays 
less important changes in the flow rate of its mixtures with 
metronidazole. 
The flow rate results show a different effect of GalenIQ 720 on the 
metronidazole flowability as that shown by the Compressibility 
index, where the powder flowability increases continuously. If we 
consider that the materials have a similar flowability it would be 
reasonable to expect that their mixtures also have a similar flow, as 
it is observed. The exception is the first addition of GalenIQ 720 
which increases the flow rate. This effect is attributed to a partial 
disruption of continuity of the cohesive bonds between particles of 
metronidazole. 
As the flow rate stabilizes after additions of GalenIQ 720 proportions 
of 50% and higher, it was calculated the average of these flow rates 
to compare the flowability of the mixtures against that of 
metronidazole. Figure 10 depicts a higher flow rate of 
metronidazole/GalenIQ 720 mixtures compared to the flow rate of 
metronidazole alone. This higher flow rate is more noticeable with 
an increasing size of the orifice through which the powders flow.  
 
 
Fig. 10: Effect of the orifice diameter on the flow rate of 
metronidazole and its mixtures with GalenIQ 720. 
 
 
Fig. 11: Effect of the Helmcel 200 proportion on the 
compressibility index of its mixtures with metronidazole, 
expressed as the average obtained when using funnels with 
different size openings. 
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Figure 11 depicts the change in the compressibility index of 
metronidazole (currently CI = 12.1%) after addition of different 
proportions of Helmcel 200 (currently CI = 21.7%). It is observed a 
progressive increase in the compressibility index as the proportion 
of Helmcel 200 increases, which stands for a decrease of flowability. 
The material with the higher compressibility index and the lower 
flowability, Helmcel 200, decreases progressively the flowability of 
metronidazole. 
This is an effect opposing to that observed for GalenIQ 720. GalenIQ 
720 is an excipient that improves the flow properties of 
metronidazole. Helmcel 200 would be a dysfunctional excipient that 
reduces the flow properties of metronidazole. 
Figure 12 depicts the powder flow rates of mixtures of different 
proportions of metronidazole and Helmcel 200, when flowing 
through orifices with different size. It is observed that an increasing 
proportion of Helmcel 200 decreases the powder flow rate. This is 
consistent with the results observed by the compressibility index 
(Figure 10). The reduction in the powder flow rate is linearly related 
to the ratio of the components in the mixtures, the same way as the 
compressibility index does. This implies that one could infer the 
behavior of these mixtures from the behavior of the individual 
components. 
Although the change in the flow rate of metronidazole, brought 
about by Helmcel 200, is dependent on the orifice through which the 
powder flows, in all cases the same trend is observed. The flow rate 
decreases as the proportion of Helmcel 200 in the mixture increases.  
Table 1 summarizes the comparative functionality of GalenIQ and 
Helmcel 200 to improve the flowability of metronidazole. 
Considering the compressibility index, GalenIQ 720 reduces the 
compressibility index of metronidazole by a factor of about 0.057 
pro unit percentage of the added excipient. It means a reduction of 
about 23% of its original value (12.1) after addition of 50% of the 
excipient. In contrast, Helmcel 200 increases the compressibility 
index of metronidazole by a factor of about 0.11 pro unit percentage 
of the added excipient, this means an increase of the compressibility 
index of about 47% of its original value. GalenIQ improves the 
flowability of metronidazole in 23% while Helmcel 200 worsens its 
flowability in 47%. 
 
 
Fig. 12: Effect of the Helmcel 200 proportion on the powder flow 
rate of its mixtures with metronidazole, measured with funnels 
with different size openings (mm). 
 
Table. 1: Calculated explicit functionality of GalenIQ 720 and Helmcel 200 on the flowability of metronidazole; expressed as 
compressibility index (CI) and powder flow rate. 
Material CI (%) CI (%) / excipient unit percentage Change in CI (%) by 50% excipient 
Metronidazole 12.1   
GalenIQ 720 13.8   
Helmcel 200 21.7   
Metronidazole / GalenIQ 720  -0.0568 -2.84 (-23.5%) 
Metronidazole / Helmcel 200  +0.115 +5.74 (+47.4%) 
 Flow Rate (g/s) 
6 mm opening 
Flow Rate (g/s) 
10 mm opening 
Flow Rate (g/s) 
14 mm opening 
Metronidazole 4.27 8.33 12.93 
GalenIQ 720 3.38 6.81 10.23 
Metronidazole / GalenIQ 720 (50:50) +12.6% +18.7% +23.3% 
Helmcel 200 0.261 0.959 2.26 
Metronidazole / Helmcel 200 (50:50) -57.6% -57.9% -58.1% 
 
Taking into account the flow rate, GalenIQ betters the flowability of 
metronidazole in about 23%, in a similar magnitude as that found 
using the compressibility index. However, this occurs only when the 
powder flows through a wide orifice (14 mm). The improvement of 
the powder flow becomes smaller as the orifice through which the 
powder flows decreases. The improvement becomes about a half with 
an orifice diameter of 6 mm. On the other hand, Helmcel 200 worsens 
the metronidazole flowability in about 58%, although not similar this 
value is comparable to the 47% observed by using the compressibility 
index. In this case, the proportionality of the effect on the flow rate do 
not change in an important manner as the orifice diameter changes. 
Both methods consistently show a comparable improvement of 
metronidazole flowability with GalenIQ 720 and a deterioration of 
the same with Helmcel 200. However, the comparability of results 
depend on the orifice diameter. The use of wide orifices allows a 
direct comparison while narrower orifices introduce a deviation due 
to a more perceptible interaction of the flowing powders with the 
walls of the orifice. 
The compressibility index is a specific measurement for each 
powders blend that allows the estimation of its overall flow 
properties. On the other hand, the flowability expressed as the flow 
rate displays varying results, depending of the orifice size through 
which the powders flow. Both methods exhibit comparable results 
only by wide orifice sizes where the interaction with de orifice walls 
is minimized. 
The flow rate of metronidazole formulations containing 50% 
GalenIQ 720 ranges from 4.81 g/s to 15.94 g/s while those 
containing the same proportion of Helmcel 200 ranges from 1.81 g/s 
to 5.42 g/s. Formulations containing GalenIQ 720 display a relative 
flowability 2.7-2.9 times greater than those containing Helmcel 200 
while the relative flowability of the pure excipients shows a 
flowability of GalenIQ 720 4.5-12.9 times greater than that of 
Helmcel 200. Although the flowability of GalenIQ 720 and its 
formulations is always higher than that of Helmcel 200, the presence 
of metronidazole attenuates the differences and its spread. The 
knowledge of the individual materials flowability allows the 
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inference of their effect on the flowability of their mixtures but not 
the magnitude of this effect. 
Something similar has been observed in studies carried out with 
mixtures of paracetamol with different types of celluloses. It was 
observed a trend in the direction of lesser flow rates of the celluloses 
(compressibility indexes of 15, 16 and 19) as the proportion of 
paracetamol (CI=25) increased up to 25 %. In this study, the 
flowability determined as flow rate only through a 3 mm orifice 
diameter was found to correlate with the compressibility index. It 
was considered that paracetamol reduces the flow rate of celluloses 
due to its morphology in plates and its lesser particle size. These 
particle characteristics giving to celluloses a higher cohesiveness, 
expressed as a higher compressibility index. This means that the 
powder with greater cohesiveness reduces the flowability of the 
powder with lower cohesiveness [32]. 
This same behavior has been also observed in blends of paracetamol 
and microcrystalline cellulose, using as flow parameter the values 
for the formation of a powder avalanche. The angle and energy of 
avalanche increased gradually as the ratio of paracetamol in the 
mixture increased from about 50° to 66° and from 40 kJ/kg to 120 
kJ/kg respectively. This means that the powder flow properties 
improved with an increasing amount of microcrystalline cellulose or 
a decreasing amount of paracetamol 
CONCLUSION 
[33].  
Although by definition the functionality of an excipient is bound to 
the product in which it will be used, from the viewpoint of excipient 
functionality is a technological property of the material. This 
property can be defined independently of the formulation in which it 
will be used. The compressibility index is a specific measurement for 
each powders blend that allows the assessment of its overall flow 
properties. On the other hand, the flowability, expressed as the flow 
rate, shows so many different results as orifices are being tested. Both 
methods exhibit comparable results only by wide orifice sizes where 
the interaction with de orifice walls is minimized. However, in some 
cases the results are comparable only qualitatively although 
quantitatively they can be quite different. The flow rate increases 
progressively, mostly in a potential relationship, with an increasing 
orifice diameter. The presented experimental data confirm that the 
addition of magnesium stearate improves the flowability of GalenIQ 
720, attaining a maximum to decrease thereafter. However, in some 
cases the flowability attains the maximum and maintain it with 
increasing proportions of the lubricant. Magnesium stearate 
increases the flow rate of GalenIQ 720 by about 43 % while the 
compressibility index points to an increase of flowability greater 
than 100%. Both methods consistently show an improvement of 
flowability of metronidazole after addition of GalenIQ 720 and a 
deterioration of the same after addition of Helmcel 200. 
Formulations containing GalenIQ 720 show an about 2.8 times 
greater flowability than those containing Helmcel 200. Even if the 
flowability of pure GalenIQ 720 is about 8.7 times greater than that 
of pure Helmcel 200. The presence of metronidazole attenuates the 
differences in flowability of the excipients and its spread. The 
knowledge of the individual materials flowability allows the 
inference of their effect on the flowability of their mixtures but not 
the magnitude of this effect. 
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